keyword
https://read.qxmd.com/read/38652474/psychotropic-medication-prescribing-for-children-and-adolescents-after-the-onset-of-the-covid-19-pandemic
#1
JOURNAL ARTICLE
Zaba Valtuille, Eric Acquaviva, Vincent Trebossen, Naim Ouldali, Aurelie Bourmaud, Stéphane Sclison, Alexandre Gomez, Alexis Revet, Hugo Peyre, Richard Delorme, Florentia Kaguelidou
IMPORTANCE: Numerous studies have provided evidence for the negative associations of the COVID-19 pandemic with mental health, but data on the use of psychotropic medication in children and adolescents after the onset of the COVID-19 pandemic are lacking. OBJECTIVE: To assess the rates and trends of psychotropic medication prescribing before and over the 2 years after the onset of the COVID-19 pandemic in children and adolescents in France. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used nationwide interrupted time-series analysis of outpatient drug dispensing data from the IQVIA X-ponent database...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38645173/%C3%AE-arrestin-biased-allosteric-modulator-of-neurotensin-receptor-1-reduces-ethanol-drinking-and-responses-to-ethanol-administration-in-rodents
#2
Graydon B Gereau, Diana Zhou, Kalynn J Van Voorhies, Ryan E Tyler, Jeffrey Campbell, Jackson G Murray, Ali Alvararez-Pamir, Luke Wykoff, Michel A Companion, Michael R Jackson, Steven H Olson, Lawrence S Barak, Lauren M Slosky, Ryan P Vetreno, Joyce Besheer, Zoe A McElligott
Alcohol use disorders (AUDs) impose an enormous societal and financial burden, and world-wide, alcohol misuse is the 7th leading cause of premature death1. Despite this, there are currently only 3 FDA approved pharmacological treatments for the treatment of AUDs in the United States. The neurotensin (Nts) system has long been implicated in modulating behaviors associated with alcohol misuse. Recently, a novel compound, SBI-553, that biases the action of Nts receptor 1 (NTSR1) activation, has shown promise in preclinical models of psychostimulant misuse...
April 13, 2024: bioRxiv
https://read.qxmd.com/read/38631564/%C3%AE-caryophyllene-inhibits-heroin-self-administration-but-does-not-alter-opioid-induced-antinociception-in-rodents
#3
JOURNAL ARTICLE
Ewa Galaj, Guo-Hua Bi, Zheng-Xiong Xi
A growing body of research indicates that β-caryophyllene (BCP), a constituent present in a large number of plants, possesses significant therapeutic properties against CNS disorders, including alcohol and psychostimulant use disorders. However, it is unknown whether BCP has similar therapeutic potential for opioid use disorders. In this study, we found that systemic administration of BCP dose-dependently reduced heroin self-administration in rats under an FR2 schedule of reinforcement and partially blocked heroin-enhanced brain stimulation reward in DAT-cre mice, maintained by optical stimulation of midbrain dopamine neurons at high frequencies...
April 15, 2024: Neuropharmacology
https://read.qxmd.com/read/38615923/the-association-of-caffeine-and-nandrolone-decanoate-modulates-aversive-memory-and-nociception-in-rats
#4
JOURNAL ARTICLE
Daniel Bussinger de Souza Penna, Samara Gumiéro Costa, Alexandre Dos Santos-Rodrigues, Pablo Pandolfo
Caffeine and anabolic-androgenic steroids (AAS) are commonly used to improve muscle mass and athletic performance. Nandrolone Decanoate (ND) is one of the most abused AAS worldwide, leading to behavioral changes in both humans and rodents. Caffeine, the most widely consumed psychostimulant globally, is present in various thermogenic and gym supplements. Low and moderate doses of caffeine antagonize adenosine receptors and have been linked to improved memory and pain relief. We have previously demonstrated that consuming caffeine prevents the risk-taking behavior triggered by nandrolone...
April 12, 2024: Brain Research
https://read.qxmd.com/read/38609318/psychosis-with-use-of-amphetamine-drugs-methylphenidate-and-atomoxetine-in-adolescent-and-adults
#5
JOURNAL ARTICLE
Jacques Hamard, Vanessa Rousseau, Geneviève Durrieu, Philippe Garcia, Antoine Yrondi, Agnès Sommet, Alexis Revet, François Montastruc
BACKGROUND: Use of psychostimulants and relative drugs has increased worldwide in treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents and adults. Recent studies suggest a potential association between use of psychostimulants and psychotic symptoms. The risk may not be the same between different psychostimulants. OBJECTIVE: To assess whether amphetamine or atomoxetine use is associated with a higher risk of reporting symptoms of psychosis than methylphenidate use in adolescents and adults, particularly in patients with ADHD...
April 12, 2024: BMJ Ment Health
https://read.qxmd.com/read/38595974/toluene-alters-the-intrinsic-excitability-and-excitatory-synaptic-transmission-of-basolateral-amygdala-neurons
#6
JOURNAL ARTICLE
Kevin Braunscheidel, Michael Okas, John J Woodward
INTRODUCTION: Inhalant abuse is an important health issue especially among children and adolescents who often encounter these agents in the home. Research into the neurobiological targets of inhalants has lagged behind that of other drugs such as alcohol and psychostimulants. However, studies from our lab and others have begun to reveal how inhalants such as the organic solvent toluene affect neurons in key addiction related areas of the brain including the ventral tegmental area, nucleus accumbens and medial prefrontal cortex...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38593008/dysfunctional-hippocampal-prefrontal-network-underlies-a-multidimensional-neuropsychiatric-phenotype-following-early-life-seizure
#7
JOURNAL ARTICLE
Rafael Naime Ruggiero, Danilo Benette Marques, Matheus Teixeira Rossignoli, Jana Batista De Ross, Tamiris Prizon, Ikaro Jesus Silva Beraldo, Lezio Soares Bueno-Junior, Ludmyla Kandratavicius, Jose Eduardo Peixoto-Santos, Cleiton Lopes-Aguiar, Joao Pereira Leite
Brain disturbances during development can have a lasting impact on neural function and behavior. Seizures during this critical period are linked to significant long-term consequences such as neurodevelopmental disorders, cognitive impairments, and psychiatric symptoms, resulting in a complex spectrum of multimorbidity. The hippocampus-prefrontal cortex (HPC-PFC) circuit emerges as a potential common link between such disorders. However, the mechanisms underlying these outcomes and how they relate to specific behavioral alterations are unclear...
April 9, 2024: ELife
https://read.qxmd.com/read/38587323/preventive-effects-of-crocin-a-natural-compound-from-saffron-against-nicotine%C3%A2-induced-oxidative-stress-and-neurobehavioral-disturbances
#8
JOURNAL ARTICLE
Majid Motaghinejad, Manijeh Motevalian, Antoni Sureda
Nicotine is a psychostimulant that induces neurochemical and behavioral changes upon chronic administration, leading to neurodegenerative conditions associated with smoking. As of now, no preventive or therapeutic strategies are known to counteract nicotine‑induced neurodegeneration. In this study, we explore the neuroprotective effects of crocin, a bioactive agent commonly found in saffron - a spice derived from the flower of Crocus sativus - using a rat model. The dose‑dependent effects of crocin were evaluated in nicotine‑induced neurodegeneration and compared with a control group...
March 28, 2024: Acta Neurobiologiae Experimentalis
https://read.qxmd.com/read/38582939/the-selective-d-3-receptor-antagonist-vk4-116-reverses-loss-of-insight-caused-by-self-administration-of-cocaine-in-rats
#9
JOURNAL ARTICLE
Marios C Panayi, Shohan Shetty, Micaela Porod, Lisette Bahena, Zheng-Xiong Xi, Amy Hauck Newman, Geoffrey Schoenbaum
Chronic psychostimulant use causes long-lasting changes to neural and cognitive function that persist after long periods of abstinence. As cocaine users transition from drug use to abstinence, a parallel transition from hyperactivity to hypoactivity has been found in orbitofrontal-striatal glucose metabolism and striatal D2 /D3 -receptor activity. Targeting these changes pharmacologically, using highly selective dopamine D3 -receptor (D3 R) antagonists and partial agonists, has shown promise in reducing drug-taking, and attenuating relapse in animal models of cocaine and opioid use disorder...
April 6, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38582619/hospitalized-cocaine-detoxification-patients-in-paris-france-increased-patient-levels-and-changing-population-characteristics-since-2011
#10
JOURNAL ARTICLE
Virgile Clergue-Duval, Arthur Lyonnet, Julien Azuar, Romain Icick, Margaux Poireau, Dorian Rollet, Namik Taright, Frank Questel, Isabelle Gasquet, Florence Vorspan
AIM OF THE STUDY: The past twenty years have seen a rise in cocaine-related statistics in France, including cocaine use in the general population, emergency ward presentations of acute cocaine intoxication, cocaine use disorders related outpatient appointments and cocaine-related deaths. This study's objectives were to describe trends in patients' admission for specific cocaine detoxification as well as changes in patients' characteristics in the Assistance publique-Hôpitaux de Paris (AP-HP) hospitals group located in Paris region, France...
March 26, 2024: Thérapie
https://read.qxmd.com/read/38578676/estimated-number-of-injection-involved-overdose-deaths-in-us-states-from-2000-to-2020-secondary-analysis-of-surveillance-data
#11
JOURNAL ARTICLE
Eric William Hall, Patrick Sean Sullivan, Heather Bradley
BACKGROUND: In the United States, both drug overdose mortality and injection-involved drug overdose mortality have increased nationally over the past 25 years. Despite documented geographic differences in overdose mortality and substances implicated in overdose mortality trends, injection-involved overdose mortality has not been summarized at a subnational level. OBJECTIVE: We aimed to estimate the annual number of injection-involved overdose deaths in each US state from 2000 to 2020...
April 5, 2024: JMIR Public Health and Surveillance
https://read.qxmd.com/read/38562456/protective-effects-of-amphetamine-and-methylphenidate-against-dopaminergic-neurotoxicants-in-sh-sy5y-cells
#12
JOURNAL ARTICLE
Patrícia Carneiro, Mariana Ferreira, Vera Marisa Costa, Félix Carvalho, João Paulo Capela
Full treatment of the second most common neurodegenerative disorder, Parkinson's disease (PD), is still considered an unmet need. As the psychostimulants, amphetamine (AMPH) and methylphenidate (MPH), were shown to be neuroprotective against stroke and other neuronal injury diseases, this study aimed to evaluate their neuroprotective potential against two dopaminergic neurotoxicants, 6-hydroxydopamine (6-OHDA) and paraquat (PQ), in differentiated human dopaminergic SH-SY5Y cells. Neither cytotoxicity nor mitochondrial membrane potential changes were seen following a 24-hour exposure to either therapeutic concentration of AMPH or MPH (0...
2024: Current research in toxicology
https://read.qxmd.com/read/38559006/5-ht1b-receptors-mediate-dopaminergic-inhibition-of-vesicular-fusion-and-gaba-release-from-striatonigral-synapses
#13
Maya Molinari, Ori J Lieberman, David Sulzer, Emanuela Santini, Anders Borgkvist
The substantia nigra pars reticulata (SNr), a crucial basal ganglia output nucleus, contains a dense expression of dopamine D1 receptors (D1Rs), along with dendrites belonging to dopaminergic neurons of substantia nigra pars compacta. These D1Rs are primarily located on the terminals of striatonigral medium spiny neurons, suggesting their involvement in the regulation of neurotransmitter release from the direct pathway in response to somatodendritic dopamine release. To explore the hypothesis that D1Rs modulate GABA release from striatonigral synapses, we conducted optical recordings of striatonigral activity and postsynaptic patch-clamp recordings from SNr neurons in the presence of dopamine and D1R agonists...
March 14, 2024: bioRxiv
https://read.qxmd.com/read/38555909/impact-of-the-early-covid-19-pandemic-on-adult-mental-health-related-dispensed-medications-hospitalizations-and-specialist-outpatient-visits-in-norway-and-sweden-interrupted-time-series-analysis
#14
JOURNAL ARTICLE
David Moreno-Martos, Jing Zhao, Huiqi Li, Fredrik Nyberg, Ludvig Daae Bjørndal, Mohammadhossein Hajiebrahimi, Björn Wettermark, Mia Aakjær, Morten Andersen, Maurizio Sessa, Angela Lupattelli, Hedvig Nordeng, Daniel R Morales
AIMS: Norway and Sweden had different early pandemic responses that may have impacted mental health management. The aim was to assess the impact of the early COVID-19 pandemic on mental health-related care. METHODS: We used national registries in Norway and Sweden (1 January 2018-31 December 2020) to define 2 cohorts: (i) general adult population; and (ii) mental health adult population. Interrupted times series regression analyses evaluated step and slope changes compared to prepandemic levels for monthly rates of medications (antidepressants, antipsychotics, anxiolytics, hypnotics/sedatives, lithium, opioid analgesics, psychostimulants), hospitalizations (for anxiety, bipolar, depressive/mood, eating and schizophrenia/delusional disorders) and specialist outpatient visits...
March 31, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38548247/methamphetamine-increases-risky-choice-in-rats-but-only-when-magnitude-and-probability-of-reinforcement-are-manipulated-within-a-session
#15
JOURNAL ARTICLE
Justin R Yates, Shreeukta Adhikari, Rayah E Bako, Kevin L Berling, Maria R Broderick, Reuben Mains, Bradley Zwick
Risky choice is associated with maladaptive behaviors, particularly substance use disorders. Current animal models of risky choice are often confounded by other constructs like behavioral flexibility and suboptimal choice. The purpose of the current experiment was to determine if the psychostimulant methamphetamine, a drug whose popularity has increased in recent years, increases risky choice in an equivalent expected value (EEV) task. In the EEV task, rats are given a choice between two reinforcer alternatives that differ in magnitude and probability of delivery, but have equivalent expected value...
March 26, 2024: Pharmacology, Biochemistry, and Behavior
https://read.qxmd.com/read/38547742/brain-iron-concentration-in-childhood-adhd-a-systematic-review-of-neuroimaging-studies
#16
REVIEW
Hugo A E Morandini, Prue A Watson, Parma Barbaro, Pradeep Rao
Iron deficiency may play a role in the pathophysiology of Attention Deficit/Hyperactivity Disorder (ADHD). Due to its preponderant function in monoamine catecholamine and myelin synthesis, brain iron concentration may be of primary interest in the investigation of iron dysregulation in ADHD. This study reviewed current evidence of brain iron abnormalities in children and adolescents with ADHD using magnetic resonance imaging methods, such as relaxometry and quantitative susceptibility mapping, to assess brain iron estimates...
March 23, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38546775/attention-deficit-and-hyperactivity-disorder-and-use-of-psychostimulants-in-aotearoa-new-zealand-exploring-the-treatment-gap
#17
JOURNAL ARTICLE
Steven Lillis
Introduction Attention deficit and hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting about 7% of those aged up to 12 years, 5% of teenagers and 3% of adults. It is associated with poor academic performance, substance abuse, criminality, poor social functioning and other negative outcomes. Psychotherapeutic treatment is moderately successful, whereas pharmacotherapy with stimulant medication is more efficacious and is recommended in many international guidelines. Anecdotal evidence suggests underuse of these medications in Aotearoa, New Zealand...
March 2024: Journal of Primary Health Care
https://read.qxmd.com/read/38541192/metaphedrone-3-methylmethcathinone-pharmacological-clinical-and-toxicological-profile
#18
REVIEW
Igor Kelečević, Ana-Marija Vejnović, Jovan Javorac, Nemanja Gvozdenović, Nataša Janjić, Vesna Mijatović Jovin
Introduction: Synthetic cathinones are a group of novel psychoactive substances used as an alternative to classical recreational drugs. As a result of legal prohibitions on older generations of these compounds, new formulations appeared on the drug market. One of them is metaphedrone (3-methylmethcathinone, 3-MMC), a structural isomer of 4-methylmethcathinone and a psychostimulant drug. Metaphedrone became popular in a large number of countries in a short period of time. The aim: The collection, analysis, and review of relevant research on the subject of metaphedrone in order to present information about the pharmacological, clinical, and toxicological profile of this compound...
March 12, 2024: Medicina
https://read.qxmd.com/read/38541067/clinical-variables-and-peripheral-biomarkers-associated-with-substance-induced-psychotic-disorder-differences-related-to-alcohol-cannabis-and-psychostimulant-abuse
#19
JOURNAL ARTICLE
Martina Di Paolo, Antonia Calabrese, Guido Nosari, Valentina Ciappolino, Luisa Cirella, Alice Caldiroli, Enrico Capuzzi, Massimo Clerici, Massimiliano Buoli
Background: The present retrospective observational study aims to identify differences in clinical features and peripheral biomarkers among patients affected by substance-induced psychotic disorder (SIPD) according to the primary substance of abuse. Methods: A sample of 218 patients was divided into three groups according to the type of consumed substance: alcohol, cannabis, and psychostimulants. The three groups were compared using one-way analyses of variance (ANOVAs) for continuous variables and χ2 tests for qualitative variables...
March 21, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38527696/illicitly-manufactured-fentanyl-use-among-individuals-in-the-u-s-2022
#20
JOURNAL ARTICLE
Joseph J Palamar
INTRODUCTION: While morbidity and mortality related to synthetic opioids such as illicitly manufactured fentanyl (IMF) are monitored in the U.S., there has been a lack of national survey data focusing on use. Survey data are important as self-report can help estimate prevalence of use among living persons. METHODS: Data were examined from the 2022 National Survey on Drug Use and Health, a nationally representative probability sample of noninstitutionalized individuals age ≥12 in the U...
March 23, 2024: American Journal of Preventive Medicine
keyword
keyword
20838
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.